News | May 14, 2025
Bayer confirms 2025 targets after solid start to the year
EBITDA before special items decreases to €4.08 billion (7.4%)
EBITDA before special items decreases to €4.08 billion (7.4%)
Over the last 24 years, the company's sales has grown from Rs. 478 crores to Rs. 19,022 crores
This Product is indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension
Delivers robust earnings performance, successfully navigating a dynamic environment
The partnership provides Sai Life Sciences with a greenhouse gas emissions reduction of up to 90% for its international logistics needs by using SAF
By integrating Rockwell Automation’s FactoryTalk Optix, NKP Pharma has achieved compliance with USFDA 21 CFR Part 11
Over the last two years, Lupin has showcased exceptional improvement in its EcoVadis scoring
Overall investment in the US facility is estimated around US$50 million
Yearbook members are selected basis their S&P Global 2024 Corporate Sustainability Assessment score
Sarat Kumar has been appointed as CFO of the company and also designated as Key Managerial Personnel with effect from February 21, 2025
Subscribe To Our Newsletter & Stay Updated
